|
ONVO
|
Organovo Holdings, Inc.
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
US
|
NASDAQ
|
|
PHAR
|
Pharming Group N.V.
|
US
|
NASDAQ
|
|
PHIO
|
Phio Pharmaceuticals Corp.
|
US
|
NASDAQ
|
|
PLX
|
Protalix BioTherapeutics, Inc.
|
US
|
AMEX
|
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PRPO
|
Precipio, Inc.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
PSNL
|
Personalis, Inc.
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTE
|
PolarityTE, Inc.
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
US
|
NYSE
|
|
QSI
|
Quantum-Si
|
US
|
NASDAQ
|
|
QTRX
|
Quanterix Corporation
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
US
|
NASDAQ
|